MSD licenses first COVID drug to UN patent pool

Molnupiravir is the first COVID-19 product to be licensed to the Medicines Patent Pool since the start of the pandemic
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: